Clinical Trial

EQUITA - A Feasibility Trial of a Faith-placed Intervention to Increase Screening Uptake in Black Adults

Study acronym: EQUITA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this randomised feasibility trial is to examine feasibility and acceptability of a co-produced and faith-placed intervention to increase uptake of breast, cervical, bowel, and abdominal aortic aneurysm (AAA) screening among Black communities in the North East of England, Leeds and Scotland, United Kingdom (UK). Participants will be invited to attend a two-hour workshop at each of the three study sites and will be randomly assigned to either the intervention group or the control group. This 24-month feasibility study will inform the development of a full-scale randomised-controlled trial co-produced for Black people that uses culturally appropriate messages that support screening for early diagnosis in this underserved group.
Trial Details
NCT Number NCT06981182
Lead Sponsor University of Sunderland
Collaborators: University of Glasgow
Conditions Breast Cancer, Bowel Cancer, Cervical Cancer, Abdominal Aortic Aneurysm
Enrollment 300 participants
Start Date 2025-09-01
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-05-20